Total Payments
$61,734
2024 Payments
$6,160
Companies
16
Transactions
63
Medicare Patients
477
Medicare Billing
$41,350
Payment Breakdown by Category
Other$22,368 (36.2%)
Travel$19,181 (31.1%)
Consulting$16,371 (26.5%)
Food & Beverage$1,824 (3.0%)
Research$1,140 (1.8%)
Education$850.00 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $19,181 | 18 | 31.1% |
| Consulting Fee | $16,371 | 8 | 26.5% |
| Honoraria | $11,813 | 4 | 19.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,555 | 3 | 17.1% |
| Food and Beverage | $1,824 | 27 | 3.0% |
| Unspecified | $1,140 | 2 | 1.8% |
| Education | $850.00 | 1 | 1.4% |
Payments by Type
General
$60,594
61 transactions
Research
$1,140
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Deciphera Pharmaceuticals Inc. | $25,193 | 29 | $0 (2024) |
| F. Hoffmann-La Roche AG | $23,575 | 5 | $0 (2020) |
| ROCHE MOLECULAR SYSTEMS, INC. | $3,515 | 10 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $3,500 | 1 | $0 (2021) |
| Aadi Bioscience, Inc. | $1,550 | 2 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $1,252 | 1 | $0 (2022) |
| COVIDIEN LP | $1,140 | 2 | $0 (2018) |
| Medtronic, Inc. | $750.00 | 1 | $0 (2022) |
| Intera Oncology, Inc | $345.04 | 1 | $0 (2023) |
| Daiichi Sankyo Inc. | $263.35 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,160 | 11 | Deciphera Pharmaceuticals Inc. ($6,112) |
| 2023 | $10,785 | 20 | Deciphera Pharmaceuticals Inc. ($6,442) |
| 2022 | $9,541 | 17 | Deciphera Pharmaceuticals Inc. ($5,889) |
| 2021 | $7,628 | 4 | Deciphera Pharmaceuticals Inc. ($4,000) |
| 2020 | $7,590 | 2 | F. Hoffmann-La Roche AG ($4,840) |
| 2019 | $18,864 | 6 | F. Hoffmann-La Roche AG ($18,735) |
| 2018 | $575.65 | 2 | COVIDIEN LP ($550.00) |
| 2017 | $590.00 | 1 | Covidien LP ($590.00) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Consulting Fee | Cash or cash equivalent | $620.00 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Consulting Fee | Cash or cash equivalent | $595.00 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Honoraria | Cash or cash equivalent | $3,100.00 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Travel and Lodging | In-kind items and services | $655.10 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Travel and Lodging | In-kind items and services | $437.96 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Travel and Lodging | In-kind items and services | $295.79 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $192.50 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $96.60 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $80.50 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $38.50 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $48.39 | General |
| Category: DESMOID TUMORS | ||||||
| 12/01/2023 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Consulting Fee | Cash or cash equivalent | $3,718.75 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2023 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Travel and Lodging | Cash or cash equivalent | $2,054.30 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2023 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | Cash or cash equivalent | $26.15 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2023 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | Cash or cash equivalent | $24.52 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2023 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | Cash or cash equivalent | $22.62 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2023 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | Cash or cash equivalent | $0.91 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2023 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Consulting Fee | Cash or cash equivalent | $595.00 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2023 | ROCHE MOLECULAR SYSTEMS, INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| 06/19/2023 | ROCHE MOLECULAR SYSTEMS, INC. | — | Food and Beverage | In-kind items and services | $87.00 | General |
| 06/19/2023 | ROCHE MOLECULAR SYSTEMS, INC. | — | Travel and Lodging | In-kind items and services | $33.00 | General |
| 06/19/2023 | ROCHE MOLECULAR SYSTEMS, INC. | — | Food and Beverage | In-kind items and services | $20.16 | General |
| 05/02/2023 | ROCHE MOLECULAR SYSTEMS, INC. | — | Education | In-kind items and services | $850.00 | General |
| 05/02/2023 | ROCHE MOLECULAR SYSTEMS, INC. | — | Travel and Lodging | In-kind items and services | $475.00 | General |
| 05/02/2023 | ROCHE MOLECULAR SYSTEMS, INC. | — | Travel and Lodging | In-kind items and services | $51.48 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Coyote Device Evaluation July 2017 | Covidien LP | $590.00 | 1 |
| LAPAE 1ST FORMATIVE LAB | COVIDIEN LP | $550.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 134 | 176 | $51,575 | $11,167 |
| 2022 | 4 | 113 | 134 | $37,942 | $9,290 |
| 2021 | 6 | 133 | 167 | $53,269 | $13,233 |
| 2020 | 4 | 97 | 121 | $39,218 | $7,660 |
Total Patients
477
Total Services
598
Medicare Billing
$41,350
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 47 | $11,148 | $2,394 | 21.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $8,957 | $1,937 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 26 | $8,924 | $1,805 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 24 | 35 | $8,300 | $1,796 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 20 | $6,956 | $1,529 | 22.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 23 | $3,174 | $892.32 | 28.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 12 | $4,116 | $814.20 | 19.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 18 | 18 | $10,350 | $2,759 | 26.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $6,325 | $1,677 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 31 | 39 | $7,956 | $1,623 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 28 | $5,712 | $1,561 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 15 | $4,425 | $970.07 | 21.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 18 | 23 | $3,174 | $700.45 | 22.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 27 | 41 | $12,914 | $3,301 | 25.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 20 | 20 | $11,624 | $3,113 | 26.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 18 | 19 | $8,358 | $2,384 | 28.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 29 | 35 | $7,518 | $1,876 | 25.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 13 | 13 | $6,461 | $1,356 | 21.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 26 | 39 | $6,394 | $1,203 | 18.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 23 | 23 | $14,651 | $3,120 | 21.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 28 | 34 | $11,356 | $2,158 | 19.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 26 | 35 | $7,875 | $1,424 | 18.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 20 | 29 | $5,336 | $957.02 | 17.9% |
About Dr. Jason Sicklick, M.D
Dr. Jason Sicklick, M.D is a Surgery healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1487700779.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Sicklick, M.D has received a total of $61,734 in payments from pharmaceutical and medical device companies, with $6,160 received in 2024. These payments were reported across 63 transactions from 16 companies. The most common payment nature is "Travel and Lodging" ($19,181).
As a Medicare-enrolled provider, Sicklick has provided services to 477 Medicare beneficiaries, totaling 598 services with total Medicare billing of $41,350. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgery
- Other Specialties Surgery, Surgical Oncology
- Location La Jolla, CA
- Active Since 01/27/2007
- Last Updated 11/17/2025
- Taxonomy Code 208600000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487700779
Products in Payments
- Non-Covered Product (Drug) $23,575
- QINLOCK (Drug) $21,193
- FYARRO (Drug) $1,550
- Vitrakvi (Drug) $1,252
- LigaSure (Device) $590.00
- LIGASURE (Device) $550.00
- Intera 3000 Implantable Pump (Device) $345.04
- FOUNDATIONONE (Device) $101.70
- Echelon; Endopath (Device) $100.65
- GORE VIABAHN VBX Balloon Expandable Endo (Device) $98.35
- OGSIVEO (Drug) $48.39
- Enseal (Device) $29.51
- ENSEAL Product Family (Device) $26.98
- TISSEEL (Biological) $25.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in La Jolla
Angeles Baquerizo
Surgery — Payments: $147,583
Surgery $147,583
Dr. Matthew Schultzel, D.o, D.O
Surgery — Payments: $75,161
Surgery $75,161
Pascal Bortz, M.d, M.D
Surgery — Payments: $60,673
Surgery $60,673
Dr. Sunil Bhoyrul, M.d, M.D
Surgery — Payments: $47,604
Surgery $47,604
Dr. Amy Lightner, Md, MD
Surgery — Payments: $42,964
Surgery $42,964
Dr. Mark Takata, Md, MD
Surgery — Payments: $38,605
Surgery $38,605